Literature DB >> 6147108

Narcotic bowel syndrome treated with clonidine. Resolution of abdominal pain and intestinal pseudo-obstruction.

J E Sandgren, M S McPhee, N J Greenberger.   

Abstract

We describe the cases of five patients having a syndrome of chronic abdominal pain, vomiting, weight loss, and features of intestinal pseudo-obstruction associated with prolonged use or abuse of narcotic analgesics. In each patient, abdominal complaints were originally attributed to either mechanical bowel obstruction or an underlying gastrointestinal disorder often involving prior abdominal surgery. Symptoms resolved rapidly in all patients when narcotic administration was stopped. Clonidine therapy was used to alleviate symptoms of narcotic analgesic withdrawal. The narcotic bowel syndrome is a clinically important and frequently unrecognized cause of chronic abdominal pain.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6147108     DOI: 10.7326/0003-4819-101-3-331

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  14 in total

Review 1.  Management of gastrointestinal motility disorders. A practical guide to drug selection and appropriate ancillary measures.

Authors:  J R Malagelada; E Distrutti
Journal:  Drugs       Date:  1996-10       Impact factor: 9.546

Review 2.  The narcotic bowel syndrome: a recent update.

Authors:  Douglas Drossman; Eva Szigethy
Journal:  Am J Gastroenterol Suppl       Date:  2014-09-10

Review 3.  The irritable bowel syndrome.

Authors:  S M Collins
Journal:  CMAJ       Date:  1988-02-15       Impact factor: 8.262

4.  The narcotic bowel syndrome: clinical features, pathophysiology, and management.

Authors:  David M S Grunkemeier; Joseph E Cassara; Christine B Dalton; Douglas A Drossman
Journal:  Clin Gastroenterol Hepatol       Date:  2007-10       Impact factor: 11.382

Review 5.  New perspectives in the diagnosis and management of enteric neuropathies.

Authors:  Charles H Knowles; Greger Lindberg; Emanuele Panza; Roberto De Giorgio
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-02-12       Impact factor: 46.802

6.  Opioid bowel dysfunction and narcotic bowel syndrome: a population-based study.

Authors:  Rok Seon Choung; G Richard Locke; Alan R Zinsmeister; Cathy D Schleck; Nicholas J Talley
Journal:  Am J Gastroenterol       Date:  2009-04-14       Impact factor: 10.864

7.  The effect of Helicobacter pylori infection and eradication in patients with gastro-oesophageal reflux disease: A parallel-group, double-blind, placebo-controlled multicentre study.

Authors:  Werner Schwizer; Dieter Menne; Kurt Schütze; Michael Vieth; Reiner Goergens; Peter Malfertheiner; Andreas Leodolter; Michael Fried; Mark R Fox
Journal:  United European Gastroenterol J       Date:  2013-08       Impact factor: 4.623

8.  Demonstration of intrathecal and systemic morphine and ST-91 effects on fed canine upper gut motility.

Authors:  G M Thomforde; J R Malagelada; M Camilleri; T L Yaksh
Journal:  Dig Dis Sci       Date:  1990-10       Impact factor: 3.199

9.  A case of narcotic bowel syndrome successfully treated with clonidine.

Authors:  V Wong; G Sobala; M Losowsky
Journal:  Postgrad Med J       Date:  1994-02       Impact factor: 2.401

10.  Opioids and the gastrointestinal tract - a case of narcotic bowel syndrome and literature review.

Authors:  Adam D Farmer; Ella Ferdinand; Qasim Aziz
Journal:  J Neurogastroenterol Motil       Date:  2013-01-08       Impact factor: 4.924

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.